Business Description
Awakn Life Sciences Corp
NAICS : 541714
SIC : 3741
ISIN : CA05455W1086
Description
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.22 | |||||
Equity-to-Asset | -0.87 | |||||
Debt-to-Equity | -2.62 | |||||
Debt-to-EBITDA | -0.3 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -61.73 | |||||
Beneish M-Score | -18.32 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 43.63 | |||||
9-Day RSI | 48.34 | |||||
14-Day RSI | 50.92 | |||||
6-1 Month Momentum % | -36.84 | |||||
12-1 Month Momentum % | -62.5 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.51 | |||||
Quick Ratio | 0.51 | |||||
Cash Ratio | 0.27 | |||||
Days Sales Outstanding | 21.05 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -58.8 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | -40.34 | |||||
Operating Margin % | -452.18 | |||||
Net Margin % | -322.38 | |||||
FCF Margin % | -134.37 | |||||
ROA % | -199.75 | |||||
ROIC % | -368.39 | |||||
ROC (Joel Greenblatt) % | -503.85 | |||||
ROCE % | -1093.89 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 2.42 | |||||
EV-to-EBIT | -0.67 | |||||
EV-to-EBITDA | -0.73 | |||||
EV-to-Forward-EBITDA | -0.52 | |||||
EV-to-Revenue | 2.96 | |||||
EV-to-Forward-Revenue | 2.2 | |||||
EV-to-FCF | -2.9 | |||||
Earnings Yield (Greenblatt) % | -150.12 | |||||
FCF Yield % | -41.73 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Awakn Life Sciences Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | 2.06 | ||
EPS (TTM) (C$) | -0.24 | ||
Beta | 0 | ||
Volatility % | 96.26 | ||
14-Day RSI | 50.92 | ||
14-Day ATR (C$) | 0.022988 | ||
20-Day SMA (C$) | 0.17975 | ||
12-1 Month Momentum % | -62.5 | ||
52-Week Range (C$) | 0.055 - 0.375 | ||
Shares Outstanding (Mil) | 39.02 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Awakn Life Sciences Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Awakn Life Sciences Corp Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
Awakn Life Sciences Corp Frequently Asked Questions
What is Awakn Life Sciences Corp(XCNQ:AWKN)'s stock price today?
When is next earnings date of Awakn Life Sciences Corp(XCNQ:AWKN)?
Does Awakn Life Sciences Corp(XCNQ:AWKN) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |